LONDON, Aug 25 (Reuters) - An experimental COVID-19 vaccine
being developed by the University of Oxford and AstraZeneca
could be put before regulators this year if scientists
are able to gather enough data, the director of the Oxford
Vaccine Group said on Tuesday.
"It is just possible that if the cases accrue rapidly in the
clinical trials, that we could have that data before regulators
this year, and then there would be a process that they go
through in order to make a full assessment of the data," Andrew
Pollard told BBC Radio.
(Reporting by Kate Holton and Sarah Young; editing by Alistair
Smout)